Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients
Table 4
Cohort characteristics before propensity score matching (PSM), reflecting differing percentages of characteristics (conditions, and outcome of death) with standardized mean differences (SMD) for those prescribed a specific statin compared to the control cohort not treated with a statin.